TRVN Market Cap History
Below is a table of the TRVN market cap history going back to 3/17/2014:

Date TRVN Market Cap
3/17/2014221.46M
5/5/2014130.21M
8/8/2014157.11M
11/4/2014166.74M
3/10/2015221.71M
5/4/2015273.13M
8/5/2015278.18M
11/5/2015548.28M
3/3/2016460.14M
5/2/2016398.09M
8/1/2016333.42M
10/31/2016255.39M
3/3/2017238.23M
4/28/2017190.65M
7/31/2017155.81M
10/31/201793.45M
3/2/2018119.85M
4/27/2018126.42M
7/31/2018117.17M
11/2/201858.45M
3/11/2019133.91M
5/8/2019136.68M
8/5/201986.74M
11/1/201991.95M
3/10/202067.72M
5/5/202095.39M
8/7/2020313.28M
10/30/2020411.42M
3/5/2021337.06M
5/4/2021274.84M

Also see: TRVN Shares Outstanding History
and TRVN YTD Return
TRVN Historical Market Cap:
+3.07% CAGR
TRVN Historical Market Cap: +3.07% CAGR

Mouse over chart for data details
3/17/2014 ...5/4/2021
Trevena is a biopharmaceutical company focused on the development and commercialization of treatment options that target and treat diseases affecting the central nervous system. Using its proprietary product platform, Co. has identified and are developing the following product candidates: Oliceridine injection, a G protein biased mu-opioid receptor (MOR), ligand, for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor; TRV734, a new chemical entity, targeting the same mechanism of action at the MOR as oliceridine; and TRV045, a set of S1P modulators that may provide a non-opioid approach to managing chronic pain. We show 30 historical shares outstanding datapoints in our TRVN shares outstanding history coverage, used to compute TRVN market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing TRVN market cap history over the course of time is important for investors interested in comparing TRVN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of TRVN versus a peer is one thing; comparing TRVN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like TRVN can fluctuate over the course of history. With this page we aim to empower investors researching TRVN by allowing them to research the TRVN market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for TRVN:
TRVN SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Trevena (TRVN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

TSRO Market Cap History
TTNP Market Cap History
TTOO Market Cap History
TTPH Market Cap History
TVTY Market Cap History
TXMD Market Cap History
TYME Market Cap History
UHS Market Cap History
USPH Market Cap History
UTHR Market Cap History
More Healthcare companies »

 

TRVN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.